News

Lilly’s Cialis approved for benign prostatic hyperplasia

BY Alaric DeArment

INDIANAPOLIS — The Food and Drug Administration has approved a new use for a drug made by Eli Lilly for erectile dysfunction, Lilly said Friday.

The FDA approved Cialis (tadalafil) as a once-daily treatment for men with erectile dysfunction and benign prostatic hyperplasia, also known as BPH, as well as for BPH alone. BPH is a condition in which the prostate enlarges, which can cause urinary symptoms.

"Since many men who have ED also experience the signs and symptoms of BPH, a single medication approved to treat both may be a significant therapeutic option for men and physicians," University of Texas Southwestern Medical Center Department of Urology chairman Claus Roehrborn said. "The FDA approval of Cialis for once-daily use for the treatment of ED and the signs and symptoms of BPH provides a new option that allows men to treat both with one daily medication."


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Merck’s Juvisync approved for Type 2 diabetes, high cholesterol

BY Alaric DeArment

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug that it called the first single-pill combination treatment for Type 2 diabetes and high cholesterol.

The FDA approved Merck’s Juvisync (sitagliptin and simvastatin), manufactured by Merck subsidiary MSD International GmbH Clonmel Co., based in Tipperary, Ireland. Merck operates under the name MSD outside the United States and Canada in order to avoid confusion with Germany-based Merck KGaA.

"This is the first product to combine a Type 2 diabetes drug with a cholesterol-lowering drug in one tablet," FDA Division of Metabolism and Endocrinology Products director Mary Parks said. "However, to ensure safe and effective use of this product, tablets containing different doses of sitagliptin and simvastatin in fixed-dose combination have been developed to meet the different needs of individual patients."

Of the 26 million Americans with diabetes, about 20 million have Type 2 diabetes and often have high cholesterol levels as well.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Kroger raises $1.5 million to support USO

BY Allison Cerra

CINCINNATI — Kroger announced that its annual Honoring Our Heroes fundraising campaign to support the United Service Organizations garnered $1.5 million.

The funds were raised in partnership with customers and associates through a variety of in-store activities at Kroger stores nationwide, as well as online at HonoringOurHeroes.com. Procter & Gamble and Anheuser Busch also participated in the program and contributed $250,000 each in conjunction with special sales programs in Kroger stores.

All of the funds raised will support the broad range of programs and services the USO provides to service members, their families and our veterans, Kroger said.

"We are forever grateful to our military men and women and their families for their service and sacrifice," Kroger group VP corporate affairs Lynn Marmer said. "The spirit of giving displayed by Kroger’s customers and associates in this year’s Honoring Our Heroes campaign exceeded our expectations. Their generosity will support the USO’s work to lift the spirits of America’s troops and their families."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?